FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental labeling application for HALOPERIDOL from Zydus Lifesciences Limited, updating the existing product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Psychosis
• Schizophrenia
• Tourette Syndrome

Drugs mentioned

• HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL)